CompaniesBiotech & healthDoccla UK Limited
Download
Company intelligence · Prepared from public filings

Doccla UK Limited

ACTIVENo. 12206481Incorporated 13 Sept 2019Londonvirtual wards and remote monitoring
Register data as of 27 Aug 2026
54 filings read · view all sources ↓
Watch this company
Raised, filed rounds
£39.4m
Priced rounds
3
Peak step-up
6.7x
Peak implied valuation
£141.8m
Last allotment
Jul 2024
The press said
£35m Series B led by Lakestar, valuation undisclosed (2 Sept 2024) · source ↗
Announcements are claims; the figures below are computed from filed documents. Announced valuations are usually fully diluted, so the register-implied figure reads below the headline.
Exhibit 1

Implied valuation at each priced allotment, 2021 to 2024

Implied post-money, GBP · price per share beneath each point · from SH01 filings
£39.7m£79.4m£119.1m£158.8m202120222023202417 Aug 2021: £10.5m implied post-money at £8.14 per share23 Aug 2022: £33.7m implied post-money at £24.26 per share17 Jul 2024: £141.8m implied post-money at £54.42 per share£10.5m£8.14/sh£33.7m£24.26/sh£141.8m£54.42/sh
Source: Companies House, forms SH01 filed by Doccla UK Limited; Tero analysis. Each point is one filed allotment; click any point to open the underlying filing.
Exhibit 2

Funding rounds, as filed

AllottedShare classPrice / shareRaisedImplied post-moneyStep vs priorSource
17 Jul 2024SERIES B-1 PREFERRED, SERIES B-2 PREFERRED£54.42£34.7m£141.8m▲ 2.2xSH01 ↗
23 Aug 2022Ordinary£24.26£2.3m£33.7m▲ 3.0xSH01 ↗
17 Aug 2021Seed Preferred Shares£8.14£2.4m£10.5mfirstSH01 ↗
Total, 3 priced rounds£39.4m
Source: Companies House filing history, company 12206481. Every row links to the filed document it was read from. Prices and share counts as filed; implied post-money is price per share times shares in issue after the allotment.
Methodology
Notes. Raised is the sum of shares allotted times price per share across priced allotments filed on form SH01. Peak step-up is the highest price per share divided by the first priced round. Implied post-money is price per share times shares in issue after the allotment: an approximation that ignores class rights and unexercised options. Allotments classified as option-scheme or nominal issues are excluded from the trajectory.
Primary documents
Every figure on this page is read from a document filed at Companies House and links to it. The full record is public: filing history of Doccla UK Limited at Companies House ↗. Tero retains an archived copy of each parsed filing. Information, not investment advice.